Macro molecule-based STING pathway modulators are currently being evaluated as monotherapies, By Roots Analysis

Mar 15, 2021

10 likes | 17 Views

In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing volume of scientific literature (1,000 articles published since 2015) on this subject), but also industry stakeholders focused on drug development (evident in the growing number of clinical trials and the grants awarded for STING focused projects in the recent past). To order this 310 page report, which features 170 figures and 200 tables, please visit this - https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html The USD 2.8 billion (by 2030) financial opportunity within the STING pathway targeting technologies market has been analysed across the following segments: uf0a7tTypes of Payment uf0a7tUpfront Payments uf0a7tMilestone Payments uf0a7tType of STING Modulator uf0a7tAgonist uf0a7tAntagonist uf0a7tKey Therapeutic Area(s) uf0a7tOncological Disorders uf0a7tInflammatory Disorders uf0a7tInfectious Diseases uf0a7tOthers uf0a7tRoute of Administration uf0a7tIntratumoral uf0a7tIntravenous uf0a7tOral uf0a7tSubcutaneous uf0a7tOthers uf0a7tType of Molecule uf0a7tNon-nucleotide uf0a7tCyclic Dinucleotide uf0a7tLive Biotherapeutics uf0a7tOncolytic Peptides uf0a7tSynthetic Peptides uf0a7tOthers uf0a7tKey Geographical Regions uf0a7tNorth America uf0a7tEurope uf0a7tAsia-Pacific The STING Pathway Targeting Therapeutics and Technologies, 2020-2030. report features the following companies, which we identified to be key players in this domain: uf0a7tAduro Biotech uf0a7tBristol Myers Squibb uf0a7tEisai uf0a7tGlaxoSmithKline uf0a7tImmuneSensor Therapeutics uf0a7tMerck uf0a7tNoxopharm uf0a7tSpring Bank Pharmaceuticals uf0a7tSynlogic Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. STING Pathway Targeting Therapeutics: Current Market Landscape 5. STING Pathway Targeting Technologies: Current Market landscape 6. Company Profiles 7. Academic Grant Analysis 8. STING Related Initiatives of Big Pharmaceutical Players 9. Start-up Health Indexing 10. Publication Analysis 11. Partnerships and Collaborations 12. Funding and Investment Analysis 13. Market Sizing and Opportunity Analysis 14. Executive Insights 15. Concluding Remarks 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organizations To purchase a copy, please visit https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html Contact Details Gaurav Chaudhary 1 (415) 800 3415 gaurav.chaudhary@rootsanalysis.com

kevin987

Download Presentation

Macro molecule-based STING pathway modulators are currently being evaluated as monotherapies, By Roots Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D